Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Juergen Thiele, Hans Michael Kvasnicka, Thomas Steinberg, Rudolf Zankovich, Robert Fischer & Volker Diehl. (1992) Survival in Primary (Idiopathic) Osteomyelofibrosis, so-called Agnogenic Myeloid Metaplasia. Leukemia & Lymphoma 6:4-5, pages 389-399.
Read now
Read now
Marie-Claire Martyré. (1991) Platelet PDGF and TGF-β Levels in Myeloproliferative Disorders. Leukemia & Lymphoma 6:1, pages 1-6.
Read now
Read now
Arumugam Manoharan, R. C. Smart & W. R. Pitney. (1982) Prognostic Factors in Myelofibrosis. Pathology 14:4, pages 455-461.
Read now
Read now
Articles from other publishers (35)
Görgün Akpek, David Mcaneny & Lewis Weintraub. (2001) Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: A retrospective analysis of 26 cases. Journal of Surgical Oncology 77:1, pages 42-48.
Crossref
Crossref
Jen C Wang & Chi Chen. (1998) N-RAS oncogene mutations in patients with agnogenic myeloid metaplasia in leukemic transformation. Leukemia Research 22:7, pages 639-643.
Crossref
Crossref
D. Quaglino, G. Di Leonardo, N. Furia, E. Pasqualoni & A. Campitelli. (2013) Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations. Aging Clinical and Experimental Research 9:6, pages 383-390.
Crossref
Crossref
S. Rupoli, L. Da Lio, S. Sisti, G. Campanati, A. Salvi, M. F. Brianzoni, S. D'Amico, A. Cinciripini & P. Leoni. (1994) Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival. Annals of Hematology 68:4, pages 205-212.
Crossref
Crossref
Hans Carl Hasselbalch. (1993) Idiopathic myelofibrosis — an update with particular reference to clinical aspects and prognosis. International Journal of Clinical & Laboratory Research 23:1-4, pages 124-138.
Crossref
Crossref
Taizo Tasaka, Masami Nagai, Satoshi Murao, Masahiro Yamaguchi, Akira Kitanaka, Kazunori Sasaki, Michio Murata, Terukazu Tanaka, Hiroko Kuwabara, Kazuma Ikeda, Jiro Takahara & Shozo Irino. (2006) Cd7, CD34‐positive stem cell leukemia arising in agnogenic myeloid metaplasia. American Journal of Hematology 44:1, pages 53-57.
Crossref
Crossref
T. Buhr, A. Georgii & H. Choritz. (1993) Myelofibrosis in Chronic Myeloproliferative Disorders. Pathology - Research and Practice 189:2, pages 121-132.
Crossref
Crossref
David S. Rosenthal. (1992) Clinical Aspects of Chronic Myeloproliferative Diseases. The American Journal of the Medical Sciences 304:2, pages 109-124.
Crossref
Crossref
Hans Hasselbalch. (2009) Idiopathic myelofibrosis: A review. European Journal of Haematology 45:2, pages 65-72.
Crossref
Crossref
Hans Hasselbalch. (2006) Idiopathic myelofibrosis: A clinical study of 80 patients. American Journal of Hematology 34:4, pages 291-300.
Crossref
Crossref
Hans Hasselbalch & Bjarne Anker Jensen. (2009) Prognostic factors in idiopathic myelofibrosis: A simple scoring system with prognostic significance. European Journal of Haematology 44:3, pages 172-178.
Crossref
Crossref
Juergen Thiele, Rudolf Zankovich, Thomas Steinberg, Robert Fischer & Volker Diehl. (2007) Agnogenic myeloid metaplasia (AMM)—correlation of bone marrow lesions with laboratory data: A longitudinal clinicopathological study on 114 patients. Hematological Oncology 7:5, pages 327-343.
Crossref
Crossref
H. J. Iland & J. Laszlo. 1986. Hematologic Malignancies. Hematologic Malignancies
31
61
.
Richard E. Wilson, David S. Rosenthal, William C. Moloney & Robert T. Osteen. (1985) Splenectomy for myeloproliferative disorders. World Journal of Surgery 9:3, pages 431-436.
Crossref
Crossref
J. Bruce Miller, Joseph R. Testa, Valerie Lindgren & Janet D. Rowley. (1985) The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer 55:3, pages 582-591.
Crossref
Crossref
A. Manoharan & W. R. Pitney. (2009) Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scandinavian Journal of Haematology 33:5, pages 453-459.
Crossref
Crossref
Aaron Polliack, Rachel Leizerowitz, Abraham Kornberg, Dorit Gurfel & Haim Gamliel. 1984. Human Leukemias. Human Leukemias
105
121
.
J. R. O'Donnell, M. A. Farrell, M. X. Fitzgerald & L. G. O'Connell. (1982) Agnogenic myeloid metaplasia preceded by repeated leukemoid reactions and persistent acquired Pelger-Hu?t anomaly of granulocytes. Case report with review of acquired Pelger-Hu?t anomaly. Cancer 50:8, pages 1498-1505.
Crossref
Crossref
Aaron Polliack, Miron Prokocimer & Yaacov Matzner. (2006) Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. American Journal of Hematology 9:2, pages 211-220.
Crossref
Crossref
J. Benbassat, S. Penchas & M. Ligumski. (2008) Splenectomy in Patients with Agnogenic Myeloid Metaplasia: an Analysis of 321 Published Cases. British Journal of Haematology 42:2, pages 207-214.
Crossref
Crossref
Yves Najean, Roberto Cacchione, Hugo Castro‐Malaspina & Catherine Dresch. (2008) Erythrokinetic Studies in Myelofibrosis: Their Significance for Prognosis. British Journal of Haematology 40:2, pages 205-217.
Crossref
Crossref
M. Ligumski, A. Polliack & J. Benbassat. (2009) Nature and Incidence of Liver Involvement in Agnogenic Myeloid Metaplasia. Scandinavian Journal of Haematology 21:2, pages 81-93.
Crossref
Crossref
G. Chikkappa, A. L. Carsten, A. D. Chanana, P. Chandra & E. P. Cronkite. (2006) Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia. American Journal of Hematology 4:2, pages 121-131.
Crossref
Crossref
Joel S. Greenberger, John T. Chaffey, David S. Rosenthal & William C. Moloney. (1977) Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasia. International Journal of Radiation Oncology*Biology*Physics 2:11-12, pages 1083-1090.
Crossref
Crossref
Joel S. Greenberger, Linda R. Hassan, Abraham Karpas, Dennis S. France & William C. Moloney. (2009) Leucocyte Alkaline Phosphatase Elevation in Human Acute Leukaemia Derived Cell Lines Cultured in Diffusion Chambers. Scandinavian Journal of Haematology 19:3, pages 242-254.
Crossref
Crossref
David S. Rosenthal & William C. Moloney. (2008) Occurrence of Acute Leukaemia in Myeloproliferative Disorders. British Journal of Haematology 36:3, pages 373-382.
Crossref
Crossref
John Laszlo & Andrew T. Huang. (1977) Diagnosis and management of myeloproliferative disorders. Current Problems in Cancer 2:1, pages 1-42.
Crossref
Crossref
H. Mulder, J. Steenbergen & C. Haanen. (2008) Clinical Course and Survival after Elective Splenectomy in 19 Patients with Primary Myelofibrosis. British Journal of Haematology 35:3, pages 419-427.
Crossref
Crossref
William Curry Moloney. (1977) Natural History of Chronic Granulocytic Leukaemia. Clinics in Haematology 6:1, pages 41-53.
Crossref
Crossref
Cavit Cehreli, Ediz Z. Ezdinli, Chin Y. Li & Eva Krmpotic. (1976) Blastic phase of agnogenic myeloid metaplasia simulating malignant lymphoma. Cancer 38:3, pages 1297-1305.
Crossref
Crossref
Baruch Modan. (1975) Inter-relationship between Polycythaemia Vera, Leukaemia and Myeloid Metaplasia. Clinics in Haematology 4:2, pages 427-439.
Crossref
Crossref
Nils Söderström, Ulf Bandmann & Bengt Lundh. (1975) Patho-anatomical Features of the Spleen and Liver. Clinics in Haematology 4:2, pages 309-329.
Crossref
Crossref
P. Alexander, G. Chomette, H. Hamperl, D. K. Hossfeld, L. G. Koss, R. Laumonier, H. F. Oettgen, M. F. Rajewsky, A. A. Sandberg, L. H. Sobin, H. Tulinius & S. WatanabeAvery A. Sandberg & Dieter K. Hossfeld. 1974. Geschwülste · Tumors I. Geschwülste · Tumors I
141
287
.
Arthur T. Skarin, Yoshiro Matsuo & William C. Moloney. (1972) Muramidase in myeloproliferative disorders terminating in acute leukemia. Cancer 29:5, pages 1336-1342.
Crossref
Crossref
Leon Morgenstern. (1971) Splenectomy for massive splenomegaly due to myel?id metaplasia. The American Journal of Surgery 122:2, pages 288-293.
Crossref
Crossref